Product Information
KEVZARA 200 MG/1.14 ML SYRINGE is a brand product labeled by Sanofi-Aventis U.S. LLC, priced at $2066.4821 per ML under NDC 00024591001. Its NADAC has been published 36 times since Dec 17, 2025.
Strength
200 mg/1.14mL
Manufacturer
Sanofi-Aventis U.S. LLCNDC
00024591001
Classification
Brand
Dosage Form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Effective Date
1/1/2026
Active Ingredients
SARILUMABApproval Type
Biologic (BLA)
FDA Application
BLA761037On Market Since
5/22/2017
Pharmacological Classes
Price Statistics
The NADAC for KEVZARA 200 MG/1.14 ML SYRINGE has been published 36 times since Dec 17, 2025, and over the history we have for it it has risen 6.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2066.4821 per ML |
|---|---|
| All-time high | $2066.4821 (Aug 19, 2026) |
| All-time low | $1949.5114 (Dec 17, 2025) |
| 52-week high | $2066.4821 |
| 52-week low | $1949.5114 |
| Median price | $2066.4821 |
| Average price | $2056.7345 |
| Largest weekly change | +6.0% (Jan 7, 2026) |
| Weeks tracked | 36 |
| Tracking since | Dec 17, 2025 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of KEVZARA 200 MG/1.14 ML SYRINGE?
The current National Average Drug Acquisition Cost (NADAC) for KEVZARA 200 MG/1.14 ML SYRINGE, manufactured by Sanofi-Aventis U.S. LLC, is $2066.4821 per ML (NDC 00024591001), effective Aug 19, 2026.
How has the price of KEVZARA 200 MG/1.14 ML SYRINGE changed over time?
Over the history we have for it, the NADAC for KEVZARA 200 MG/1.14 ML SYRINGE has risen 6.0%. It has been tracked across 36 weekly CMS publications since Dec 17, 2025.
What are the highest and lowest recorded NADAC prices for KEVZARA 200 MG/1.14 ML SYRINGE?
Since Dec 17, 2025, the NADAC for KEVZARA 200 MG/1.14 ML SYRINGE has ranged from a low of $1949.5114 (Dec 17, 2025) to a high of $2066.4821 (Aug 19, 2026), with a median of $2066.4821 per ML.
Are there cheaper alternatives to KEVZARA 200 MG/1.14 ML SYRINGE?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as KEVZARA 200 MG/1.14 ML SYRINGE in a comparable dosage form, but none are currently priced below it.
Who manufactures KEVZARA 200 MG/1.14 ML SYRINGE?
KEVZARA 200 MG/1.14 ML SYRINGE (NDC 00024591001) is labeled by Sanofi-Aventis U.S. LLC, and CMS classifies it as a brand product.